Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share
Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share
In addition, Concentra has granted the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of its common stock to cover over-allotments, if any. Concentra's common stock has been approved for listing on the New York Stock Exchange under the symbol "CON" and is expected to begin trading on July 25, 2024. The IPO is expected to close on July 26, 2024, subject to the satisfaction or waiver of customary closing conditions.
此外，Concentra已授予承销商一个30天的购买期权，以购买其普通股多出的337.5万股，以应对超额配售。Concentra的普通股已获得纽约证券交易所的批准，交易标的为"CON"，预计将于2024年7月25日开始交易。首次公开发行预计在2024年7月26日结束，需满足或豁免惯常的收盘条件。
After the completion of the IPO, Select Medical will own 104,093,503 shares of Concentra's common stock, representing 82.23% of the total outstanding shares of Concentra's common stock (or 80.09% if the underwriters exercise in full their over-allotment option).
IPO完成后，Select Medical将拥有Concentra普通股的104,093,503股，占Concentra普通股总流通股的82.23％（如果承销商全部行使超额配售选择权，则为80.09％）。